Researchers has substantially improved the course of the new therapy for ATTR-CM, leveraging the investigational drug. Initial clinical results reveals promising benefits for patients diagnosed with this severe illness. https://bridgebio240772.shotblogs.com/company-advances-attr-cm-treatment-through-attruby-56288728